Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Anastrozole in Healthy Chinese Volunteers (Fed)
NCT04445922Phase 1Unknown
- Sponsor
- The Affiliated Hospital of Qingdao University
- Start
- Jul 2020
- Primary completion
- Aug 2020
- Modality
- Irreversible Covalent Inhibitors, Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of anastrozole in breast cancer, sponsored by The Affiliated Hospital of Qingdao University. Primary endpoint: Geometric Mean Ratio at 60 days. Status: unknown.
02
Drugs
anastrozole
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT04445922.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04445922.